Market Place
Sourcing Support
Wockhardt`s Zaynich Cures Complex Meningitis Case
20 Sep 2024 //
#N/A
Pharma sector demands substantial R&D incentives, tax relief & IP framework
04 Jul 2024 //
FINANCIAL EXPRESS
Orchid and Cipla collaborate to launch Cefepime-Enmetazobactam in India
29 Jun 2024 //
INDIANPHARMAPOST
Allecra & Acino Ink Agreement For Exblifep In GCC And South Africa
25 Jun 2024 //
PHARMABIZ
Orchid Pharma receives DCGI approval for Cefepime and Enmetazobactam antibiotic
13 Jun 2024 //
BIOSPECTRUM ASIA
India’s DCGI approves Orchid Pharma’s API Enmetazobactam
06 Jun 2024 //
PHARMACEUTICAL TECHNOLOGY
UK MHRA approves Advanz Pharma antibiotic for complex infections
05 Apr 2024 //
PHARMACEUTICAL TECHNOLOGY
FDA says yes to Allecra`s antibiotic combo after CRL for another
27 Feb 2024 //
FIERCE PHARMA
Venatorx and Melinta Provide Update on Status of NDA for Cefepime-Taniborbactam
23 Feb 2024 //
BUSINESSWIRE
New England Journal of Medicine Publishes Positive Results of Cefepime-Taniborbactam from Phase 3
20 Feb 2024 //
BUSINESSWIRE
Venatorx and Menarini Enter Agreement for Cefepime-Taniborbactam
09 Jan 2024 //
BUSINESSWIRE
Everest Announces NMPA Recommends Priority Review for Cefepime-Taniborbactam
19 Sep 2023 //
PR NEWSWIRE
Venatorx Receives FDA Acceptance of NDA for Cefepime-Taniborbactam
15 Aug 2023 //
PR NEWSWIRE
Venatorx Announces FDA Acceptance of NDA for Cefepime-Taniborbactam
15 Aug 2023 //
BUSINESSWIRE
Xentria & Meitheal Announce Exclusive Licensing Agreement for XTMAB-16
27 Jun 2023 //
BUSINESSWIRE
Enforcement Report - Week of May 24, 2023
24 May 2023 //
FDA
Enforcement Report - Week of February 22, 2023
22 Feb 2023 //
FDA
Venatorx Presents Data on Investigational Cefepime-Taniborbactam at IDWeek 2022
20 Oct 2022 //
BUSINESSWIRE
Allecra Therapeutics Publishes Final Phase 3 ALLIUM Data in JAMA
05 Oct 2022 //
BUSINESSWIRE
Venatorx Reports Positive Results from Phase 3 Cefepime-Taniborbactam Trial
10 Mar 2022 //
PRNEWSWIRE
Allecra, ADVANZ PHARMA Sign Exclusive Agreement for Cefepime/enmetazobactam
12 Jan 2022 //
BIOSPACE
Venatorx Pharmaceuticals Provides Update on Cefepime-Taniborbactam
17 Aug 2021 //
BUSINESSWIRE
Venatorx Pharma to Present Data on Cefepime-Taniborbactam at IDWeek 2020
21 Oct 2020 //
BUSINESSWIRE
Venatorx & GARDP Partner to Develop New Antibiotic for Hospital Infections
29 Apr 2020 //
YAHOO
Venatorx Pharma & GARDP Partner to Develop New Antibiotic for Hospital
28 Apr 2020 //
BUSINESSWIRE
VenatoRx beings ph3 trial of Cefepime/VNRX-5133 in patients with complicated UTI
03 Sep 2019 //
PHARMABIZ
Hospira Healthcare India Pvt. Ltd. on FDA Import Alert List
01 Aug 2018 //
FDA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.